SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001831283-23-000141
Filing Date
2023-12-20
Accepted
2023-12-20 08:05:09
Documents
14
Period of Report
2023-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lian-20231219.htm   iXBRL 8-K 34499
2 EX-99.1 a991-lianbiopressreleaseis.htm EX-99.1 5151
6 image_0.jpg GRAPHIC 85718
  Complete submission text file 0001831283-23-000141.txt   295266

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lian-20231219.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lian-20231219_lab.xml EX-101.LAB 25850
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lian-20231219_pre.xml EX-101.PRE 13581
8 EXTRACTED XBRL INSTANCE DOCUMENT lian-20231219_htm.xml XML 2966
Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Filer) CIK: 0001831283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40947 | Film No.: 231499405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)